Glaukos Announces Participation in Wells Fargo Healthcare Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 5, 2018, at 1:15 p.m. EDT in Boston, MA. A live audio webcast for this eve

Full Story →